FDA Determines Regulatory Review Period for TRIVASCULAR OVATION ABDOMINAL STENT GRAFT SYSTEM Patent Extension

Summary

The U.S. Food and Drug Administration (FDA) has officially set a regulatory review period for the TRIVASCULAR OVATION ABDOMINAL STENT GRAFT SYSTEM, following a patent extension application submitted to the U.S. Patent and Trademark Office (USPTO)